Amexdrug Corp. (AXRX) financial statements (2020 and earlier)

Company profile

Business Address 369 SOUTH DOHENY DR SUITE 326
BEVERLY HILLS, CA 90211
State of Incorp. CA
Fiscal Year End December 31
SIC 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments168131 
Cash and cash equivalents163126 
Short-term investments55 
Receivables724640 
Inventory, net of allowances, customer advances and progress billings798833
Inventory798833 
Prepaid expense78 
Other undisclosed current assets1211 
Total current assets:1,7801,616 
Noncurrent Assets
Property, plant and equipment456474 
Intangible assets, net (including goodwill)1818
Goodwill1818 
Deposits noncurrent assets 30 
Other undisclosed noncurrent assets(426)(473) 
Total noncurrent assets:4848 
Other undisclosed assets456474 
TOTAL ASSETS:2,2852,138 
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities601397 
Accounts payable472387 
Accrued liabilities118 
Taxes payable1172 
Debt200648 
Other undisclosed current liabilities523177 
Total current liabilities:1,3231,222 
Noncurrent Liabilities
Long-term debt and lease obligation303315 
Long-term debt, excluding current maturities303315 
Total noncurrent liabilities:303315 
Total liabilities:1,6261,537 
Stockholders' equity
Stockholders' equity attributable to parent658601 
Common stock169169 
Treasury stock, value(17)(16) 
Additional paid in capital(78)(78) 
Retained earnings583525 
Total stockholders' equity:658601 
TOTAL LIABILITIES AND EQUITY:2,2852,138 

Income statement (P&L) ($ in thousands)

6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
Revenues2,1542,361 
Cost of revenue
(Cost of Goods and Services Sold)
(1,797)(1,842) 
Gross profit:357519 
Operating expenses(232)(243) 
Other undisclosed operating loss(18)(18) 
Operating income:107258 
Nonoperating expense(12)(8) 
Other nonoperating expense(12)(8) 
Interest and debt expense138 
Income from continuing operations before equity method investments, income taxes:108258 
Other undisclosed loss from continuing operations before income taxes(13)(8) 
Income from continuing operations before income taxes:95250 
Income tax expense(37)(78) 
Net income available to common stockholders, diluted:58172 

Comprehensive Income ($ in thousands)

6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
Net income:58172 
Comprehensive income, net of tax, attributable to parent:58172 

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: